Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01833 PA GOODDOCTOR
RTNominal down11.800 -0.020 (-0.169%)
Others

13/09/2019 10:59

{I-bank focus}Daiwa lifts PA Good Doctor (01833) to HK$60

[ET Net News Agency, 13 September 2019] Daiwa Research lifted its target price for Ping
An Healthcare and Technology (PA Good Doctor)(01833) to HK$60 from HK$56 and maintained
its "buy" rating.
The research house expects the recently announced official national guidance on NDRL
(National Drug Reimbursement List) inclusion of online medical services to offer more
potential opportunities for Good Doctor's online consultation business from 2020.
Daiwa said Good Doctor had 4 wholly-owned Internet hospitals in Qingdao, Yinchuan,
Nantong and Hefei as at end-August. After its online medical service being included in
NDRL, it expects a market size of CNY2.5bn just in Shandong Province. Daiwa narrowed its
losses in 2019-20 and fine-tuned its 2021 earnings mainly due to better profitability.
(KL)

Remark: Real time quote last updated: 28/03/2024 18:00
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.